Evidence map›Paper›PMID 42819482›Full record

ArticleInfection and drug resistance2026

Clinical and Microbiological Profile of

Türkan Tüzün, Sedef Zeliha Öner

Abstract read
In one paragraph

Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Türkan TüzünDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Pamukkale University, Denizli, Türkiye.ORCID 0000-0003-0603-8731
Sedef Zeliha ÖnerDepartment of Medical Microbiology, Faculty of Medicine, Pamukkale University, Denizli, Türkiye.ORCID 0000-0002-9964-2526

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To describe the clinical and microbiological profile of Patients and Methods: We retrospectively reviewed 157 consecutive clinical isolates from 146 patients recovered from September 27, 2019, through September 27, 2021. The primary between-group analysis retained one first-listed isolate per patient (n=146); Fisher's exact tests, odds ratios with 95% confidence intervals, and Holm adjustment across 12 antimicrobials were used. A generalized estimating equation analysis of all 157 isolates, clustered by patient, was performed as a sensitivity analysis. Results: Conclusion: This study provides a historical local description of

Indexed as

acquisition settingantimicrobial resistanceclinical isolatesretrospective studySerratia marcescensSerratia spp.

Identifiers

PMID42819482
PMCPMC13626005

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.